Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App-Based diabetes coaching shows promise in small trial

NCT ID NCT07513961

Disease control Sponsor: Alanya Alaaddin Keykubat University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether a nurse-led mobile app could improve diabetes management in 112 adults with type 2 diabetes. The intervention group received structured education and reminders via the app for 6 months, while the control group got standard care. The main goal was to see if the app helped lower blood sugar levels (HbA1c) and improve self-care behaviors.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Technology-Based Diabetes Education and Follow-up System (PAS-DM) - a mobile health platform providing structured education and reminders
What this could lead to
If successful, this approach could offer a scalable, low-cost way to help people with type 2 diabetes better manage their condition at home.
What could go wrong
This is a completed trial with 112 participants, so results are limited in size. The intervention requires a smartphone and internet, which may not be available to everyone. It focuses on education, not a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

112 people

The number who actually took part.

Started

Mar 2021

Finished

Mar 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 18 and 70 years. * Diagnosed with Type 2 Diabetes Mellitus for at least 6 months. * Minimum of primary school education. * Using a smartphone with an Android operating system and having internet access. * No visual, hearing, cognitive, or psychiatric impairments. * No major comorbid conditions such as cancer, advanced cardiovascular disease, chronic kidney disease, or liver disease. Exclusion Criteria: * Failure to interact with the educational/reminder messages during the intervention period. * Developing a physical condition that hinders participation in physical activity. * Requesting to withdraw from the study during the follow-up period.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetes self-management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetes self-management Glycemic control Type 2 diabetes mellitus (T2DM)

Contacts and locations

Locations

  • Alanya Alaaddin Keykubat University Training and Research Hospital, Department of Internal Medicine

    Alanya, Antalya, 07400, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.